{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:42:32Z","timestamp":1793173352076,"version":"4.5.0"},"reference-count":325,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114718","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T11:15:39Z","timestamp":1681989339000},"page":"114718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9895-8166","authenticated-orcid":false,"given":"Md Jamir","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattam Khulaif","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Hamad","family":"Alhowail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114718_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.114718_bib2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinternmed.2008.604","article-title":"Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004","volume":"169","author":"Ginde","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jsbmb.2013.11.003","article-title":"Is vitamin D deficiency a major global public health problem","volume":"144","author":"Palacios","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114718_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108841","article-title":"Vitamin D in autophagy signaling for health and diseases: insights on potential mechanisms and future perspectives","volume":"99","author":"Bhutia","year":"2022","journal-title":"J. Nutr. Biochem"},{"key":"10.1016\/j.biopha.2023.114718_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsbmb.2016.09.004","article-title":"Sunlight exposure: Do health benefits outweigh harm","volume":"175","author":"Razzaque","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114718_bib6","series-title":"Mayo Clin. Proc","first-page":"752","article-title":"Vitamin D deficiency in adults: when to test and how to treat","author":"Kennel","year":"2010"},{"key":"10.1016\/j.biopha.2023.114718_bib7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ajcn\/58.5.684","article-title":"Low serum 25-hydroxyvitamin D concentrations and secondary hyperparathyroidism in middle-aged white strict vegetarians","volume":"58","author":"Lamberg-Allardt","year":"1993","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ije\/dyn157","article-title":"Fish, human health and marine ecosystem health: policies in collision","volume":"38","author":"Brunner","year":"2009","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.biopha.2023.114718_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jhev.2000.0403","article-title":"The evolution of human skin coloration","volume":"39","author":"Jablonski","year":"2000","journal-title":"J. Hum. Evol."},{"key":"10.1016\/j.biopha.2023.114718_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-67-2-373","article-title":"Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin","volume":"67","author":"Webb","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.114718_bib11","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/archderm.1988.01670120018003","article-title":"Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D: a preliminary study","volume":"124","author":"Matsuoka","year":"1988","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.biopha.2023.114718_bib12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1562\/2005-02-02-IR-430","article-title":"The vitamin D3 pathway in human skin and its role for regulation of biological processes","volume":"81","author":"Lehmann","year":"2005","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.biopha.2023.114718_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-6-135","article-title":"The impact of clothing style on bone mineral density among post menopausal women in Morocco: a case-control study","volume":"6","author":"Allali","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.biopha.2023.114718_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.healthplace.2008.04.006","article-title":"Geographic location, physical activity and perceptions of the environment in Queensland adults","volume":"15","author":"Duncan","year":"2009","journal-title":"Health Place"},{"key":"10.1016\/j.biopha.2023.114718_bib15","first-page":"519","article-title":"Suppression of gamma-interferon induced HLA-DR antigen expression on normal and transformed keratinocytes by 1, 25 (OH) 2 vitamin D3","volume":"101","author":"Tone","year":"1991","journal-title":"Nihon Hifuka Gakkai Zasshi"},{"key":"10.1016\/j.biopha.2023.114718_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF00689592","article-title":"Expression of the histocompatibility glycoprotein HLA-DR in neurological disease","volume":"76","author":"McGeer","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2023.114718_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.wnr.0000136175.51954.ce","article-title":"The expression of PARP, NF-\u03baB and parvalbumin is increased in Parkinson disease","volume":"15","author":"So\u00f3s","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2023.114718_bib18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/003655201317097119","article-title":"Lactose malabsorption and intolerance in the elderly","volume":"36","author":"Di Stefano","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.114718_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ageing\/28.3.265","article-title":"Retracted: effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients","volume":"28","author":"Sato","year":"1999","journal-title":"Age Ageing"},{"key":"10.1016\/j.biopha.2023.114718_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2169\/internalmedicine.51.6897","article-title":"Risk factors for vitamin D deficiency in patients with chronic kidney disease","volume":"51","author":"Echida","year":"2012","journal-title":"Intern. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.ejcn.1602128","article-title":"Hypovitaminosis D, insulin resistance and hypertension in pregnancy","volume":"59","author":"Rutz","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1067\/mpd.2003.63","article-title":"Hypovitaminosis D and vitamin D deficiency in exclusively breast-feeding infants and their mothers in summer: a justification for vitamin D supplementation of breast-feeding infants","volume":"142","author":"Dawodu","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.biopha.2023.114718_bib23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/bjc.2017.44","article-title":"The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis","volume":"116","author":"Vaughan-Shaw","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2023.114718_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ajcn\/42.4.644","article-title":"Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes","volume":"42","author":"Lo","year":"1985","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","article-title":"Decreased bioavailability of vitamin D in obesity","volume":"72","author":"Wortsman","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.mam.2008.08.008","article-title":"The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action","volume":"29","author":"Holick","year":"2008","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174313","article-title":"An insight into the implications of estrogen deficiency and transforming growth factor \u03b2 in antiepileptic drugs-induced bone loss","author":"Anwar","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1139\/cjpp-2013-0504","article-title":"Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice","volume":"92","author":"Anwar","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2014.05.018","article-title":"Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-\u03b23 content in bone of female mice","volume":"62","author":"Anwar","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.drudis.2009.01.004","article-title":"Insights into liaison between antiepileptic drugs and bone","volume":"14","author":"Khanna","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2023.114718_bib31","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2011-1600","article-title":"Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001\u20132006","volume":"96","author":"Skversky","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.114718_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.14","article-title":"Antidepressants differentially related to 1, 25-(OH) 2 vitamin D3 and 25-(OH) vitamin D3 in late-life depression","volume":"4","author":"Oude Voshaar","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114718_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/INF.0000000000001169","article-title":"Symptomatic hypocalcemia secondary to rifampicin-induced hypovitaminosis D","volume":"35","author":"Leung","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.biopha.2023.114718_bib34","first-page":"61","article-title":"Effect of cimetidine on hepatic vitamin D metabolism in humans","volume":"46","author":"Odes","year":"1990","journal-title":"Digestion"},{"key":"10.1016\/j.biopha.2023.114718_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2796.2001.00868.x","article-title":"Effects of thiazide\u2010and loop\u2010diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study","volume":"250","author":"Rejnmark","year":"2001","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0006-3223(89)90025-5","article-title":"The effect of lithium on vitamin D metabolism","volume":"26","author":"Rosenblatt","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114718_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2318-13-38","article-title":"Laxative use and incident falls, fractures and change in bone mineral density in postmenopausal women: results from the Women\u2019s Health Initiative","volume":"13","author":"Haring","year":"2013","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.biopha.2023.114718_bib38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ajcn\/53.5.1281","article-title":"Serum 25-hydroxyvitamin D concentrations of free-living subjects consuming olestra","volume":"53","author":"Jones","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib39","first-page":"1415","article-title":"Effect of orlistat therapy on carbohydrate, lipid, vitamin and hormone plasma levels in obese subjects","volume":"112","author":"Czerwie\u0144ska","year":"2004","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.biopha.2023.114718_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2023.114718_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21186573","article-title":"An update on vitamin D metabolism","volume":"21","author":"Saponaro","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib42","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.3390\/ijms21249626","article-title":"Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies","volume":"21","author":"Ruiz-Ballesteros","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(10)60588-0","article-title":"Common genetic determinants of vitamin D insufficiency: a genome-wide association study","volume":"376","author":"Wang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.114718_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2003.10.004","article-title":"Lack of mutations in CYP2D6 and CYP27 in patients with apparent deficiency of vitamin D 25-hydroxylase","volume":"80","author":"Lin","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biopha.2023.114718_bib45","first-page":"1","article-title":"Further evidence for the association of CYP2D6* 4 gene polymorphism with Parkinson\u2019s disease: a case control study","volume":"39","author":"Aslam","year":"2017","journal-title":"Genes Environ."},{"key":"10.1016\/j.biopha.2023.114718_bib46","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/advances\/nmab074","article-title":"Vitamin D receptor gene polymorphisms and risk of Alzheimer disease and mild cognitive impairment: A systematic review and meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/cmi.2014.47","article-title":"Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case\u2013control studies","volume":"12","author":"Tizaoui","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"2013","key":"10.1016\/j.biopha.2023.114718_bib48","article-title":"The pleiotropic effect of vitamin D","author":"Lai","year":"2013","journal-title":"Int. Sch. Res. Not."},{"key":"10.1016\/j.biopha.2023.114718_bib49","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/ijms19082245","article-title":"Vitamin D in neurological diseases: a rationale for a pathogenic impact","volume":"19","author":"Moretti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.metabol.2017.01.007","article-title":"Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals","volume":"69","author":"Luthold","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2023.114718_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","article-title":"The gut microbiome in neurological disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2982.2010.01664.x","article-title":"The microbiome\u2010gut\u2010brain axis: from bowel to behavior","volume":"23","author":"Cryan","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.biopha.2023.114718_bib53","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.3390\/ijms22084288","article-title":"Vitamin D and microbiota: Is there a link with allergies?","volume":"22","author":"Murdaca","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02510-1","article-title":"The function of gut microbiota in immune-related neurological disorders: a review","volume":"19","author":"Sittipo","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.114718_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106112","article-title":"Vitamin D and microbiota: two sides of the same coin in the immunomodulatory aspects","volume":"79","author":"Malaguarnera","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib56","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2023.114718_bib57","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.3390\/ijms20235856","article-title":"IL-33\/IL-31 axis in immune-mediated and allergic diseases","volume":"20","author":"Murdaca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2014","key":"10.1016\/j.biopha.2023.114718_bib58","article-title":"25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airways","author":"Bonanno","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2023.114718_bib59","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer\u2019s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"De La Torre","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib61","doi-asserted-by":"crossref","unstructured":"S.T. Creavin, S. Wisniewski, A.H. Noel\u2010Storr, C.M. Trevelyan, T. Hampton, D. Rayment, V.M. Thom, K.J.E. Nash, H. Elhamoui, R. Milligan, Mini\u2010Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations, Cochrane Database Syst. Rev. (2016).","DOI":"10.1002\/14651858.CD011145.pub2"},{"key":"10.1016\/j.biopha.2023.114718_bib62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0891988716629858","article-title":"Cognitive deficits in healthy elderly population with \u201cnormal\u201d scores on the mini-mental state examination","volume":"29","author":"Votruba","year":"2016","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib63","article-title":"Overview of the blood biomarkers in Alzheimer\u2019s disease: promises and challenges","author":"Delaby","year":"2022","journal-title":"Rev. Neurol. (Paris)."},{"key":"10.1016\/j.biopha.2023.114718_bib64","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer\u2019s disease","volume":"42","author":"Antonell","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib65","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archneur.62.2.196","article-title":"Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies","volume":"62","author":"Mathis","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib66","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.biopha.2023.114718_bib67","first-page":"263","article-title":"The Alzheimer\u2019s disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri","year":"2019","journal-title":"Med. Clin."},{"key":"10.1016\/j.biopha.2023.114718_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib69","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/d41586-023-00030-3","article-title":"FDA approves Alzheimer\u2019s drug lecanemab amid safety concerns","volume":"613","author":"Reardon","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.114718_bib70","doi-asserted-by":"crossref","unstructured":"E. Mahase, Alzheimer\u2019s disease: FDA approves lecanemab amid cost and safety concerns, (2023).","DOI":"10.1136\/bmj.p73"},{"key":"10.1016\/j.biopha.2023.114718_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.114718_bib72","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2165\/11595870-000000000-00000","article-title":"Current and emerging drug treatment options for Alzheimer\u2019s disease: a systematic review","volume":"71","author":"Herrmann","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2023.114718_bib73","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/nu12041019","article-title":"Influence of the mediterranean and ketogenic diets on cognitive status and decline: a narrative review","volume":"12","author":"Vinciguerra","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.114718_bib74","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.celrep.2016.09.086","article-title":"Vitamin D promotes protein homeostasis and longevity via the stress response pathway genes skn-1, ire-1, and xbp-1","volume":"17","author":"Mark","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2023.114718_bib75","first-page":"3","article-title":"\u201cVitamin D\u2013why does it matter?\u201d\u2013defining vitamin D deficiency and its prevalence","volume":"72","author":"Bischoff-Ferrari","year":"2012","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.biopha.2023.114718_bib76","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.beem.2011.05.009","article-title":"Vitamin D and the brain","volume":"25","author":"Harms","year":"2011","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.114718_bib77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000334177","article-title":"Vitamin D-mentia: randomized clinical trials should be the next step","volume":"37","author":"Annweiler","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.biopha.2023.114718_bib78","first-page":"118","article-title":"Vitamin D: The \u201csunshine\u201d vitamin","volume":"3","author":"Nair","year":"2012","journal-title":"J. Pharmacol. Pharm."},{"key":"10.1016\/j.biopha.2023.114718_bib79","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.2711-13.2014","article-title":"1\u03b1, 25-Dihydroxyvitamin D3 reduces cerebral amyloid-\u03b2 accumulation and improves cognition in mouse models of Alzheimer\u2019s disease","volume":"34","author":"Durk","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib80","first-page":"263","article-title":"Redox regulation of cellular stress response in neurodegenerative disorders","volume":"55","author":"Calabrese","year":"2006","journal-title":"Ital. J. Biochem."},{"key":"10.1016\/j.biopha.2023.114718_bib81","first-page":"1","article-title":"Vitamin D status: United states, 2001\u20132006","volume":"59","author":"Looker","year":"2011","journal-title":"NCHS Data Brief."},{"key":"10.1016\/j.biopha.2023.114718_bib82","doi-asserted-by":"crossref","first-page":"381","DOI":"10.24875\/RIC.19003079","article-title":"Association of vitamin D with mild cognitive impairment and Alzheimer\u2019s dementia in older Mexican adults","volume":"71","author":"Aguilar-Navarro","year":"2019","journal-title":"Rev. Investig. Cl\u00ednica."},{"key":"10.1016\/j.biopha.2023.114718_bib83","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib84","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jalz.2013.05.1765","article-title":"Reduced 25-hydroxyvitamin D and risk of Alzheimer\u2019s disease and vascular dementia","volume":"10","author":"Afzal","year":"2014","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.biopha.2023.114718_bib85","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archinternmed.2010.173","article-title":"Vitamin D and risk of cognitive decline in elderly persons","volume":"170","author":"Llewellyn","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-019-1500-6","article-title":"Vitamin D deficiency as a risk factor for dementia and Alzheimer\u2019s disease: an updated meta-analysis","volume":"19","author":"Chai","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.13058","article-title":"Vitamin D in dementia prevention","volume":"1367","author":"Annweiler","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ggi.13821","article-title":"Effect of vitamin D on cognitive function and white matter hyperintensity in patients with mild Alzheimer\u2019s disease","volume":"20","author":"Shih","year":"2020","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.biopha.2023.114718_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.936","article-title":"Serum vitamin D in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"8","author":"Ouma","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.biopha.2023.114718_bib90","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jamda.2019.12.009","article-title":"Specific nutritional biomarker profiles in mild cognitive impairment and subjective cognitive decline are associated with clinical progression: the NUDAD project","volume":"21","author":"de Leeuw","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.biopha.2023.114718_bib91","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1210\/jc.2013-2653","article-title":"The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes","volume":"98","author":"Hollis","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.114718_bib92","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.clinbiochem.2017.09.018","article-title":"Influence of diurnal variation and fasting on serum iron concentrations in a community-based population","volume":"50","author":"Nguyen","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biopha.2023.114718_bib93","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3945\/ajcn.116.141531","article-title":"Vitamin D is not associated with incident dementia or cognitive impairment: an 18-y follow-up study in community-living old men","volume":"105","author":"Olsson","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib94","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/jgs.12032","article-title":"Calcium and vitamin D supplementation and cognitive impairment in the women\u2019s health initiative","volume":"60","author":"Rossom","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.biopha.2023.114718_bib95","first-page":"1347","article-title":"Effects of vitamin D supplementation on cognitive function and blood A\u03b2-related biomarkers in older adults with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"90","author":"Jia","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114718_bib96","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s42000-018-0086-5","article-title":"Vitamin D basis of Alzheimer\u2019s disease: from genetics to biomarkers","volume":"18","author":"Dursun","year":"2019","journal-title":"Hormones"},{"key":"10.1016\/j.biopha.2023.114718_bib97","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00198-008-0619-x","article-title":"Rapid correction of low vitamin D status in nursing home residents","volume":"19","author":"Przybelski","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.biopha.2023.114718_bib98","doi-asserted-by":"crossref","first-page":"13824","DOI":"10.18632\/aging.103510","article-title":"Vitamin D deficiency as a potential risk factor for accelerated aging, impaired hippocampal neurogenesis and cognitive decline: a role for Wnt\/\u03b2-catenin signaling","volume":"12","author":"G\u00f3mez-Oliva","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.biopha.2023.114718_bib99","doi-asserted-by":"crossref","first-page":"E4359","DOI":"10.1073\/pnas.1404477111","article-title":"Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats","volume":"111","author":"Latimer","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2023.114718_bib101","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1007\/s12035-017-0839-1","article-title":"Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer\u2019s disease","volume":"55","author":"Morello","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2023.114718_bib102","first-page":"127","article-title":"Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer\u2019s disease in rats, Alexandria","volume":"51","author":"Mohamed","year":"2015","journal-title":"J. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11011-019-00529-7","article-title":"Effects of vitamin D in an animal model of Alzheimer\u2019s disease: behavioral assessment with biochemical investigation of Hippocampus and serum","volume":"35","author":"Mehri","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117703","article-title":"Vitamin D3 attenuates lipopolysaccharide-induced cognitive impairment in rats by inhibiting inflammation and oxidative stress","volume":"253","author":"Mokhtari-Zaer","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071593","article-title":"The impact of adult vitamin D deficiency on behaviour and brain function in male Sprague-Dawley rats","volume":"8","author":"Byrne","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-nutr-071813-105557","article-title":"Vitamin D as a neurosteroid affecting the developing and adult brain","volume":"34","author":"Groves","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188605","article-title":"Vitamin D receptor is present on the neuronal plasma membrane and is co-localized with amyloid precursor protein, ADAM10 or Nicastrin","volume":"12","author":"Dursun","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib108","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.1993.tb23052.x","article-title":"Alzheimer\u2019s disease families with amyloid precursor protein mutations a","volume":"695","author":"Rossor","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib109","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2023.114718_bib110","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-020-18534-1","article-title":"Risk prediction of late-onset Alzheimer\u2019s disease implies an oligogenic architecture","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114718_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/alz.041592","article-title":"Exome sequencing identifies three novel AD\u2010associated genes: genetics\/genetic factors of Alzheimer\u2019s disease","volume":"16","author":"Holstege","year":"2020","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.biopha.2023.114718_bib112","first-page":"205","article-title":"Risk and protective factors for sporadic Alzheimer\u2019s disease","volume":"51","author":"Stozicka","year":"2007","journal-title":"Acta Virol."},{"key":"10.1016\/j.biopha.2023.114718_bib113","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02815006","article-title":"Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation","volume":"29","author":"Baum","year":"1996","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.biopha.2023.114718_bib114","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3390\/ijms18122764","article-title":"Vitamin D and its analogues decrease amyloid-\u03b2 (A\u03b2) formation and increase A\u03b2-degradation","volume":"18","author":"Grimm","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-8-20","article-title":"1\u03b1, 25-Dihydroxyvitamin D 3 enhances cerebral clearance of human amyloid-\u03b2 peptide (1-40) from mouse brain across the blood-brain barrier","volume":"8","author":"Ito","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.biopha.2023.114718_bib116","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-2012-110560","article-title":"Genomic and nongenomic signaling induced by 1\u03b1, 25 (OH) 2-vitamin D 3 promotes the recovery of amyloid-\u03b2 phagocytosis by Alzheimer\u2019s disease macrophages","volume":"29","author":"Mizwicki","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib117","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1523\/JNEUROSCI.17-18-07053.1997","article-title":"A\u03b2 deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse","volume":"17","author":"Irizarry","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1755-5949.2009.00115.x","article-title":"TGF\u2010\u03b21 pathway as a new target for neuroprotection in Alzheimer\u2019s disease","volume":"17","author":"Caraci","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2023.114718_bib119","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.neuroscience.2008.11.002","article-title":"Reduction of \u03b2-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor \u03b2","volume":"158","author":"Uribe-San Martin","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2023.114718_bib120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2005.01.003","article-title":"Transforming growth factor-\u03b21 produced by hippocampal cells modulates microglial reactivity in culture","volume":"19","author":"Herrera-Molina","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib121","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF03033981","article-title":"Pro-and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells","volume":"8","author":"Saud","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2023.114718_bib122","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1471-4159.2012.07887.x","article-title":"Modulation of interferon\u2010\u03b3\u2010induced glial cell activation by transforming growth factor \u03b21: a role for STAT1 and MAPK pathways","volume":"123","author":"Herrera\u2010Molina","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1016\/j.biopha.2023.114718_bib123","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/87945","article-title":"TGF-\u03b21 promotes microglial amyloid-\u03b2 clearance and reduces plaque burden in transgenic mice","volume":"7","author":"Wyss-Coray","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib124","first-page":"1389","article-title":"Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid","volume":"140","author":"Frautschy","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2023.114718_bib125","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/jnen\/61.9.760","article-title":"Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system","volume":"61","author":"Magnus","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbi.2013.12.018","article-title":"Age-dependent changes on TGF\u03b21 Smad3 pathway modify the pattern of microglial cell activation","volume":"37","author":"Tichauer","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2023.114718_bib127","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-4615-0123-7_13","article-title":"TGF-\u00dfs and their roles in the regulation of neuron survival","author":"Unsicker","year":"2003","journal-title":"Mol. Cell. Biol. Neuroprot. CNS"},{"key":"10.1016\/j.biopha.2023.114718_bib128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(03)00303-3","article-title":"1, 25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons","volume":"343","author":"Brown","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2023.114718_bib129","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/bi972965+","article-title":"An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts","volume":"37","author":"Veenstra","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2023.114718_bib130","unstructured":"C. Carlberg, The concept of multiple vitamin D signaling pathways, in: J. Investig. Dermatol. Symp. Proc, 1996: pp. 10\u201314."},{"issue":"283","key":"10.1016\/j.biopha.2023.114718_bib131","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.283.5406.1317","article-title":"Convergence of transforming growth factor-\u03b2 and vitamin D signaling pathways on SMAD transcriptional coactivators","volume":"80-","author":"Yanagisawa","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.114718_bib132","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fgene.2012.00200","article-title":"Calcium homeostasis in aging neurons","volume":"3","author":"Nikoletopoulou","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2023.114718_bib133","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10863-016-9672-x","article-title":"Mitochondrial Ca 2+ and regulation of the permeability transition pore","volume":"49","author":"Hurst","year":"2017","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.biopha.2023.114718_bib134","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3390\/ijms21041549","article-title":"Remodeling of intracellular Ca2+ homeostasis in rat hippocampal neurons aged in vitro","volume":"21","author":"Calvo-Rodriguez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000051244","article-title":"Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and-3, in neocortical brain areas of Alzheimer disease patients","volume":"12","author":"Braunewell","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.biopha.2023.114718_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017553","article-title":"The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons","volume":"6","author":"Gezen-Ak","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib137","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10072-012-1268-6","article-title":"Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement","volume":"34","author":"Gezen-Ak","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib138","first-page":"305","article-title":"Age-related elevation of lipid peroxidation products: diminution of superoxide dismutase activity in the central nervous system of rats","volume":"37","author":"Gupta","year":"1991","journal-title":"Gerontology"},{"key":"10.1016\/j.biopha.2023.114718_bib139","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.07.201","article-title":"Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants","volume":"336","author":"Abd El Mohsen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.114718_bib140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1734-1140(13)71003-X","article-title":"Vitamin D and the central nervous system","volume":"65","author":"Wrzosek","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2023.114718_bib141","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jsbmb.2010.03.008","article-title":"Effects of calcitriol on calbindins gene expression and lipid peroxidation in human placenta","volume":"121","author":"Halhali","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114718_bib142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajh.2830430106","article-title":"Elevated levels of heme oxygenase\u20101 activity and mRNA in peripheral blood adherent cells of acquired immunodeficiency syndrome patients","volume":"43","author":"Levere","year":"1993","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.biopha.2023.114718_bib143","first-page":"42","article-title":"Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer\u2019s disease","volume":"145","author":"Smith","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2023.114718_bib144","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-102061","article-title":"Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation","volume":"26","author":"Hui","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104893","article-title":"Vitamin D exerts neuroprotection via SIRT1\/nrf-2\/NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice","volume":"142","author":"Ali","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2023.114718_bib146","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0197-4580(00)00253-0","article-title":"Increased protein glycation in cerebrospinal fluid of Alzheimer\u2019s disease","volume":"22","author":"Shuvaev","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2023.114718_bib147","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2008.01977.x","article-title":"Calcitriol blunts pro\u2010atherosclerotic parameters through NF\u03baB and p38 in vitro","volume":"38","author":"Talmor","year":"2008","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.biopha.2023.114718_bib148","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2023.114718_bib149","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global burden of disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib150","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/ajcn\/80.3.752","article-title":"Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged\u2265 60 y","volume":"80","author":"Bischoff-Ferrari","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib151","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/oem.2010.057448","article-title":"Outdoor work and risk for Parkinson\u2019s disease: a population-based case\u2013control study","volume":"68","author":"Kenborg","year":"2011","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib152","first-page":"29","article-title":"Systematic review of the relationship between vitamin D and Parkinson\u2019s disease","volume":"6","author":"Rimmelzwaan","year":"2016","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib153","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00415-012-6697-x","article-title":"Bone mineral density and vitamin D status in Parkinson\u2019s disease patients","volume":"260","author":"Van den Bos","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib154","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archneur.65.10.1348","article-title":"Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease","volume":"65","author":"Evatt","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib155","first-page":"669","article-title":"The role of vitamin D in disease progression in early Parkinson\u2019s disease","volume":"7","author":"Sleeman","year":"2017","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib156","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","article-title":"Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease","volume":"97","author":"Suzuki","year":"2013","journal-title":"Am. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40734-018-0074-6","article-title":"Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson\u2019s disease","volume":"5","author":"Luthra","year":"2018","journal-title":"J. Clin. Mov. Disord."},{"key":"10.1016\/j.biopha.2023.114718_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203637","article-title":"A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson\u2019s disease: does age matter?","volume":"13","author":"Hiller","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib159","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.parkreldis.2010.11.018","article-title":"Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson\u2019s disease: a case-control study in Japan","volume":"17","author":"Miyake","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.biopha.2023.114718_bib160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7","article-title":"Effect of 1, 25\u2013dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L\u2010buthionine sulfoximine and 1\u2013methyl\u20104\u2013phenylpyridine","volume":"62","author":"Shinpo","year":"2000","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.biopha.2023.114718_bib161","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","article-title":"Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats","volume":"904","author":"Wang","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2023.114718_bib162","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S0891-5849(03)00105-9","article-title":"Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3","volume":"34","author":"Lin","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib163","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.21878","article-title":"1, 25\u2013Dihydroxyvitamin D3 administration to 6\u2013hydroxydopamine\u2010lesioned rats increases glial cell line\u2010derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum","volume":"87","author":"Sanchez","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2023.114718_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039227","article-title":"25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice","volume":"7","author":"Dean","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib165","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1096\/fj.201700713R","article-title":"Vitamin D regulation of GDNF\/Ret signaling in dopaminergic neurons","volume":"32","author":"Pertile","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.114718_bib166","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.brainres.2011.01.056","article-title":"Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure","volume":"1382","author":"Kosakai","year":"2011","journal-title":"Brain Res."},{"issue":"2015","key":"10.1016\/j.biopha.2023.114718_bib167","article-title":"Vitamin D and Alzheimer\u2019s disease: neurocognition to therapeutics","author":"Banerjee","year":"2015","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib168","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mce.2017.05.035","article-title":"Vitamin D and the brain: genomic and non-genomic actions","volume":"453","author":"Cui","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2023.114718_bib169","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainresbull.2004.04.015","article-title":"Impaired motor performance in mice lacking neurosteroid vitamin D receptors","volume":"64","author":"Kalueff","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2023.114718_bib170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2004.07.008","article-title":"Behavioural characterization of vitamin D receptor knockout mice","volume":"157","author":"Burne","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2023.114718_bib171","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1469-1809.2010.00631.x","article-title":"Vitamin D receptor gene as a candidate gene for Parkinson disease","volume":"75","author":"Butler","year":"2011","journal-title":"Ann. Hum. Genet"},{"key":"10.1016\/j.biopha.2023.114718_bib172","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11064-006-9048-4","article-title":"Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine","volume":"31","author":"Smith","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2023.114718_bib173","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-211-45295-0_3","article-title":"The discovery of dopamine deficiency in the parkinsonian brain","author":"Hornykiewicz","year":"2006","journal-title":"Park. Dis. Relat. Disord."},{"key":"10.1016\/j.biopha.2023.114718_bib174","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnagi.2014.00087","article-title":"Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson\u2019s disease","volume":"6","author":"Benazzouz","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14802\/jmd.20006","article-title":"Nutrition and lifestyle interventions for managing Parkinson\u2019s disease: a narrative review","volume":"13","author":"Lister","year":"2020","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.biopha.2023.114718_bib176","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","article-title":"Distribution of the vitamin D receptor and 1\u03b1-hydroxylase in human brain","volume":"29","author":"Eyles","year":"2005","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.biopha.2023.114718_bib177","doi-asserted-by":"crossref","unstructured":"M. \u0160tefanovic, E. Topi\u0107, A.M. Ivani\u0161evi\u0107, M. Relja, M. Kor\u0161i\u0107, Genotyping of CYP2D6 in Parkinsons\u2019s Disease, (2000).","DOI":"10.1515\/CCLM.2000.136"},{"key":"10.1016\/j.biopha.2023.114718_bib178","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/rej.2009.0850","article-title":"The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson\u2019s disease phenotype and nicotine-mediated neuroprotection","volume":"12","author":"Singh","year":"2009","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.biopha.2023.114718_bib179","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1749-6632.2003.tb07471.x","article-title":"Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson\u2019s disease","volume":"991","author":"Wang","year":"2003","journal-title":"Ann. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib180","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly (ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced parkinsonism","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib181","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/bj3080131","article-title":"Modulation of poly (ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells","volume":"308","author":"Bhatia","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2023.114718_bib182","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.1992.tb27446.x","article-title":"Free radical injury in skin cultured fibroblasts from Alzheimer\u2019s disease patients","volume":"673","author":"Tesco","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib183","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1042\/bst0210330","article-title":"Pathological implications of nitric oxide, superoxide and peroxynitrite formation","volume":"21","author":"Beckman","year":"1993","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2023.114718_bib184","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lab.2003.08.002","article-title":"1-\u03b1, 25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells","volume":"143","author":"Chang","year":"2004","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/138161208783597407","article-title":"Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections","volume":"14","author":"Cuadrado","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2023.114718_bib186","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jchemneu.2004.07.003","article-title":"Effects of 1\u03b1, 25 dihydroxyvitamin D3 on the expression of HO-1 and GFAP in glial cells of the photothrombotically lesioned cerebral cortex","volume":"28","author":"Oermann","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.biopha.2023.114718_bib187","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3945\/jn.116.239475","article-title":"Activation of Nrf2-antioxidant signaling by 1, 25-dihydroxycholecalciferol prevents leptin-induced oxidative stress and inflammation in human endothelial cells","volume":"147","author":"Teixeira","year":"2017","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib188","article-title":"The molecular mechanism underlining the preventive effect of vitamin D against hepatic and renal acute toxicity through the NrF2\/BACH1\/HO-1 pathway","volume":"244","author":"El-Magd","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib189","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroscience.2010.12.057","article-title":"Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson\u2019s disease","volume":"177","author":"Martella","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2023.114718_bib190","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00001756-199503000-00009","article-title":"Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice","volume":"6","author":"Kupsch","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2023.114718_bib191","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2010-101377","article-title":"A novel perspective for Alzheimer\u2019s disease: vitamin D receptor suppression by amyloid-\u03b2 and preventing the amyloid-\u03b2 induced alterations by vitamin D in cortical neurons","volume":"23","author":"Dursun","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib192","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.intimp.2009.03.003","article-title":"Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson\u2019s disease","volume":"9","author":"Kurkowska-Jastrz\u0119bska","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib193","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/jnr.21425","article-title":"PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low\u2010level oxidative stress and direct PGE2 neurotoxicity","volume":"85","author":"Carrasco","year":"2007","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.biopha.2023.114718_bib194","doi-asserted-by":"crossref","first-page":"11681","DOI":"10.1074\/jbc.M113.517581","article-title":"Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114718_bib195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0169-328X(96)00103-9","article-title":"1, 25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor","volume":"41","author":"Naveilhan","year":"1996","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.biopha.2023.114718_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062040","article-title":"Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression","volume":"8","author":"Orme","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib197","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-4159.2006.04006.x","article-title":"Differential effect of nerve growth factor on dopaminergic neurotoxin\u2010induced apoptosis","volume":"99","author":"Hirata","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2023.114718_bib198","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1097-4547(20010301)63:5<402::AID-JNR1035>3.0.CO;2-F","article-title":"Nerve growth factor prevents 1\u2013methyl\u20104\u2013phenyl\u20101, 2, 3, 6\u2013tetrahydropyridine\u2010induced cell death via the Akt pathway by suppressing caspase\u20103\u2013like activity using PC12 cells: Relevance to therapeutical application for parkinson\u2019s disease","volume":"63","author":"Shimoke","year":"2001","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.biopha.2023.114718_bib199","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1074\/jbc.M209164200","article-title":"Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner","volume":"278","author":"Salinas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114718_bib200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1210\/endo.138.1.4858","article-title":"1, 25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs","volume":"138","author":"Musiol","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2023.114718_bib201","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4274\/npa.y7076","article-title":"The effect of vitamin D treatment on nerve growth factor (NGF) release from hippocampal neurons","volume":"51","author":"Gezen-Ak","year":"2014","journal-title":"N\u00f6ro Psikiyatr. Ar\u015fivi."},{"key":"10.1016\/j.biopha.2023.114718_bib202","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.nut.2012.11.018","article-title":"Vitamin D levels in Alzheimer\u2019s and Parkinson\u2019s diseases: a meta-analysis","volume":"29","author":"Zhao","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2023.114718_bib203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2016.09.013","article-title":"Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson\u2019s disease","volume":"370","author":"Gatto","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmhg.2016.08.004","article-title":"Vitamin D receptor gene variants in Parkinson\u2019s disease patients","volume":"18","author":"Meamar","year":"2017","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"10.1016\/j.biopha.2023.114718_bib205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.biopha.2023.114718_bib207","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2023.114718_bib208","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-52898-8.00006-9","article-title":"The epidemiology of the epilepsies","volume":"107","author":"Neligan","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib209","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.114718_bib210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","article-title":"Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care","volume":"7","author":"St","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib211","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neurol.2015.11.005","article-title":"Vitamin D deficiency and its role in neurological conditions: a review","volume":"172","author":"Mpandzou","year":"2016","journal-title":"Rev. Neurol. (Paris)."},{"key":"10.1016\/j.biopha.2023.114718_bib212","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmj.2.5913.258","article-title":"\u201cAnticonvulsant action\u201d of vitamin D in epileptic patients? A controlled pilot study","volume":"2","author":"Christiansen","year":"1974","journal-title":"Br. Med J."},{"key":"10.1016\/j.biopha.2023.114718_bib213","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.pediatrneurol.2010.03.004","article-title":"Prevalence and risk factors for vitamin D insufficiency among children with epilepsy","volume":"42","author":"Shellhaas","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib214","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","article-title":"Low vitamin D levels are common in patients with epilepsy","volume":"108","author":"Teagarden","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.biopha.2023.114718_bib215","first-page":"48","article-title":"Association of 25-hydroxyvitamin D deficiency in pediatric epileptic patients","volume":"11","author":"Chaudhuri","year":"2017","journal-title":"Iran. J. Child Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib216","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1157.1979.tb04771.x","article-title":"Antiepileptic drugs and vitamin D supplementation","volume":"20","author":"Offermann","year":"1979","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2023.114718_bib217","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/epi.13443","article-title":"Vitamin D deficiency and its risk factors in Malaysian children with epilepsy","volume":"57","author":"Fong","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2023.114718_bib218","first-page":"77","article-title":"Serum level of vitamin D and febrile seizure? A clinical study","volume":"14","author":"Heydarian","year":"2020","journal-title":"Iran. J. Child Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib219","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1684\/epd.2021.1268","article-title":"Vitamin D deficiency in a Portuguese epilepsy cohort: who is at risk and how to treat","volume":"23","author":"Cunha","year":"2021","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.biopha.2023.114718_bib220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.seizure.2019.06.009","article-title":"Valproate decreases vitamin D levels in pediatric patients with epilepsy","volume":"71","author":"Xu","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.biopha.2023.114718_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106840","article-title":"Vitamin D status of untreated children and adolescent Egyptian patients with genetic generalized epilepsy: a case\u2013control study","volume":"103","author":"Elmazny","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2023.114718_bib222","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2012.03.011","article-title":"Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study","volume":"24","author":"Holl\u00f3","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2023.114718_bib223","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yebeh.2019.03.001","article-title":"Safety and tolerability of Vitamin D3 5000 IU\/day in epilepsy","volume":"94","author":"DeGiorgio","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2023.114718_bib224","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.seizure.2018.04.008","article-title":"Calcium metabolism serum markers in adult patients with epilepsy and the effect of vitamin D supplementation on seizure control","volume":"58","author":"Tombini","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.biopha.2023.114718_bib225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(84)91153-3","article-title":"Administration of 1, 25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats","volume":"298","author":"Siegel","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2023.114718_bib226","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainresbull.2005.06.022","article-title":"Anticonvulsant effects of 1, 25-dihydroxyvitamin D in chemically induced seizures in mice","volume":"67","author":"Kalueff","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2023.114718_bib227","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2005.10.007","article-title":"Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene","volume":"394","author":"Kalueff","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2023.114718_bib228","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2007.07.002","article-title":"Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock","volume":"573","author":"Borowicz","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib229","first-page":"78","article-title":"Ghamdi, Vitamin D enhances antiepileptic and cognitive effects of lamotrigine in pentylenetetrazole-kindled rats","volume":"2017","author":"Abdel-Wahab","year":"1673","journal-title":"Brain Res.."},{"key":"10.1016\/j.biopha.2023.114718_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2019.106208","article-title":"Effects of vitamin D and paricalcitol on epileptogenesis and behavioral properties of WAG\/Rij rats with absence epilepsy","volume":"157","author":"Aygun","year":"2019","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.biopha.2023.114718_bib231","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/ijms19092735","article-title":"Voltage-dependent calcium channels, calcium binding proteins, and their interaction in the pathological process of epilepsy","volume":"19","author":"Xu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib232","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1523\/JNEUROSCI.21-01-00098.2001","article-title":"Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons","volume":"21","author":"Brewer","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib233","first-page":"1708","article-title":"1\u03b1, 25-Dihydroxyvitamin D3 mechanism of action: modulation of L-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats, Biochim. Biophys. Acta (BBA)-Molecular","volume":"2012","author":"Zanatta","year":"1823","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2023.114718_bib234","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1523\/JNEUROSCI.5698-08.2009","article-title":"Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices","volume":"29","author":"Kov\u00e1cs","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fncel.2017.00377","article-title":"Neuronal nitric oxide synthase contributes to PTZ kindling epilepsy-induced hippocampal endoplasmic reticulum stress and oxidative damage","volume":"11","author":"Zhu","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib236","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4274\/npa.y7089","article-title":"The influence of vitamin D treatment on the inducible nitric oxide synthase (INOS) expression in primary hippocampal neurons","volume":"51","author":"Dursun","year":"2014","journal-title":"N\u00f6ro Psikiyatr. Ar\u015fivi."},{"key":"10.1016\/j.biopha.2023.114718_bib237","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/1570159X12666140923205715","article-title":"Antioxidants as a preventive treatment for epileptic process: a review of the current status","volume":"12","author":"Martinc","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib238","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib239","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000026433","article-title":"Cytokine effects on glutamate uptake by human astrocytes","volume":"7","author":"Hu","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.biopha.2023.114718_bib240","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1\u03b2 enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib241","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nbd.2015.07.003","article-title":"GABAA currents are decreased by IL-1\u03b2 in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis","volume":"82","author":"Roseti","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2023.114718_bib242","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","article-title":"Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia","volume":"185","author":"Lamkanfi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib243","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00210-017-1400-5","article-title":"Neuroprotective effects of vitamin D alone or in combination with lamotrigine against lithium-pilocarpine model of status epilepticus in rats","volume":"390","author":"Mahfoz","year":"2017","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib244","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jnr.10491","article-title":"Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line","volume":"71","author":"Lefebvre d\u2019Hellencourt","year":"2003","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.biopha.2023.114718_bib245","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.intimp.2007.09.016","article-title":"1, 25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn\u2019s disease","volume":"7","author":"Bartels","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib246","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10238-013-0249-2","article-title":"Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis","volume":"14","author":"Neve","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib247","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cellimm.2012.10.009","article-title":"Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages","volume":"280","author":"Di Rosa","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib248","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174608","article-title":"Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: a randomised double-blinded, placebo-control trial","volume":"12","author":"Komolmit","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib249","first-page":"145","article-title":"In vivo comparative study of the seizure-and ischemia-induced synthesis of eicosanoids in the brain of gerbils","volume":"328","author":"Leifke","year":"1994","journal-title":"Arch. Int. Pharmacodyn. Th\u00e9rapie."},{"key":"10.1016\/j.biopha.2023.114718_bib250","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1006\/bbrc.1996.0313","article-title":"Molecular characterization of seizure-related genes isolated by differential screening","volume":"219","author":"Kajiwara","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.114718_bib251","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0002-9440(10)65199-1","article-title":"Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2","volume":"155","author":"Kelley","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2023.114718_bib252","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1021\/acs.jafc.5b02914","article-title":"Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (Lion\u2019s Mane) mushroom fruiting bodies and mycelia and their bioactive compounds","volume":"63","author":"Friedman","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.114718_bib253","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/ijms20040859","article-title":"The neuroprotective effect of Hericium erinaceus extracts in mouse hippocampus after pilocarpine-induced status epilepticus","volume":"20","author":"Jang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib254","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.actbio.2020.09.057","article-title":"TGF\u03b23 is neuroprotective and alleviates the neurotoxic response induced by aligned poly-l-lactic acid fibers on na\u00efve and activated primary astrocytes","volume":"117","author":"Gottipati","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2023.114718_bib255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0169-328X(02)00514-4","article-title":"Kainate treatment alters TGF-\u03b23 gene expression in the rat hippocampus","volume":"108","author":"Kim","year":"2002","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.biopha.2023.114718_bib256","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/brain\/awl317","article-title":"TGF-\u03b2 receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis","volume":"130","author":"Ivens","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2023.114718_bib257","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Coles, Mult. Sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.114718_bib258","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ane.12649","article-title":"Pathology and MRI: exploring cognitive impairment in MS","volume":"134","author":"Paul","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.biopha.2023.114718_bib259","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018019","article-title":"Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis","volume":"6","author":"Pfueller","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib260","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib261","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00019052-199808000-00002","article-title":"Viruses and multiple sclerosis","volume":"11","author":"Monteyne","year":"1998","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib262","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/jnnp.2011.240432","article-title":"Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis","volume":"82","author":"Simpson","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114718_bib263","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00198-008-0626-y","article-title":"Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis","volume":"20","author":"Hagenau","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.biopha.2023.114718_bib264","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nrneurol.2016.181","article-title":"Latitude and vitamin D influence disease course in multiple sclerosis","volume":"13","author":"Wood","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-014-0226-8","article-title":"Multiple sclerosis in the far north-incidence and prevalence in Nordland County, Norway, 1970\u20132010","volume":"14","author":"Benjaminsen","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib266","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM195205082461901","article-title":"Multiple sclerosis in rural Norway: Its geographic and occupational incidence in relation to nutrition","volume":"246","author":"Swank","year":"1952","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib267","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03014469100001442","article-title":"A review of the aetiology of multiple sclerosis: an ecological approach","volume":"18","author":"Murrell","year":"1991","journal-title":"Ann. Hum. Biol."},{"key":"10.1016\/j.biopha.2023.114718_bib268","first-page":"733","article-title":"Nutrition, latitude, and multiple sclerosis mortality: an ecologic study.","volume":"142","author":"Esparza","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.biopha.2023.114718_bib269","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archneurpsyc.1953.02320250097011","article-title":"Treatment of multiple sclerosis with low-fat diet","volume":"69","author":"Swank","year":"1953","journal-title":"AMA Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114718_bib270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00207237408709641","article-title":"Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence: (A viewpoint) part 2. biochemical and genetic factors","volume":"6","author":"Goldberg","year":"1974","journal-title":"Int. J. Environ. Stud."},{"key":"10.1016\/j.biopha.2023.114718_bib271","first-page":"S55","article-title":"Diet and multiple sclerosis","volume":"49","author":"Lauer","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib272","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.ejcn.1601952","article-title":"Multiple sclerosis and vitamin D: an update","volume":"58","author":"VanAmerongen","year":"2004","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib273","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","article-title":"Sun exposure and vitamin D are independent risk factors for CNS demyelination","volume":"76","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib274","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","article-title":"Vitamin D and multiple sclerosis","volume":"216","author":"Hayes","year":"1997","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib276","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2023.114718_bib277","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","article-title":"A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing\u2013remitting multiple sclerosis","volume":"76","author":"Wingerchuk","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114718_bib278","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","article-title":"A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis","volume":"74","author":"Burton","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib279","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.msard.2016.10.005","article-title":"Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab","volume":"10","author":"Laursen","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.biopha.2023.114718_bib280","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000002316","article-title":"Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis","volume":"86","author":"Sotirchos","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib281","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/1352458515600248","article-title":"Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls","volume":"22","author":"Bhargava","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.biopha.2023.114718_bib282","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jamaneurol.2015.2742","article-title":"Association of vitamin D levels with multiple sclerosis activity and progression in patients receiving interferon beta-1b","volume":"72","author":"Fitzgerald","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib283","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","article-title":"A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis","volume":"77","author":"Stein","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib284","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1352458511434607","article-title":"Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial","volume":"18","author":"Kampman","year":"2012","journal-title":"Mult. Scler. J."},{"issue":"2012","key":"10.1016\/j.biopha.2023.114718_bib285","article-title":"Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial","author":"Shaygannejad","year":"2012","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.biopha.2023.114718_bib286","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-H\u00e4nninen","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114718_bib287","first-page":"67","article-title":"Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: preliminary findings of a randomized-controlled trial","volume":"14","author":"Etemadifar","year":"2015","journal-title":"Iran. J. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib288","article-title":"Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: a double-blind randomised controlled trial, Mult. Scler","volume":"3","author":"O\u2019Connell","year":"2017","journal-title":"J., Transl. Clin."},{"key":"10.1016\/j.biopha.2023.114718_bib289","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1212\/WNL.0000000000008445","article-title":"Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon \u03b2-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.114718_bib290","article-title":"Cholecalciferol in relapsing-remitting MS: a randomized clinical trial (CHOLINE)","volume":"6","author":"Camu","year":"2019","journal-title":"Neurol. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.114718_bib291","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-13-60","article-title":"Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties","volume":"13","author":"Golan","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib292","article-title":"High-dose vitamin D supplementation in multiple sclerosis\u2013results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial, Mult. Scler","volume":"6","author":"D\u00f6rr","year":"2020","journal-title":"J., Transl. Clin."},{"key":"10.1016\/j.biopha.2023.114718_bib293","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S8756-3282(03)00030-9","article-title":"Combination of a 1, 25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone","volume":"32","author":"Van Etten","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2023.114718_bib294","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.103.6.1311","article-title":"Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats","volume":"103","author":"Paterson","year":"1969","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib295","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","article-title":"1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis","volume":"87","author":"Lemire","year":"1991","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2023.114718_bib296","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1, 25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib297","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/00005072-199608000-00006","article-title":"1, 25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis","volume":"55","author":"Nataf","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib298","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00401-002-0663-0","article-title":"Treatment of experimental autoimmune encephalomyelitis in rat by 1, 25-dihydroxyvitamin D 3 leads to early effects within the central nervous system","volume":"105","author":"Garcion","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2023.114718_bib299","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026262","article-title":"Dietary vitamin D3 supplements reduce demyelination in the cuprizone model","volume":"6","author":"Wergeland","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114718_bib300","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/jn\/129.11.1966","article-title":"Dietary calcium is a major factor in 1, 25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice","volume":"129","author":"Cantorna","year":"1999","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2023.114718_bib301","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s000110050360","article-title":"Molecular mechanism of vitamin D receptor action","volume":"47","author":"Issa","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2023.114718_bib302","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0003-9861(02)00580-5","article-title":"The vitamin D receptor is necessary for 1\u03b1, 25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice","volume":"408","author":"Meehan","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2023.114718_bib303","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-5728(95)00076-E","article-title":"Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 \u03b1, 25-(OH) 2D3","volume":"61","author":"Branisteanu","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2023.114718_bib304","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-5728(97)00116-1","article-title":"Synergism between sirolimus and 1, 25-dihydroxyvitamin D3 in vitro and in vivo","volume":"79","author":"Branisteanu","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2023.114718_bib305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.expneurol.2013.08.002","article-title":"Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage","volume":"249","author":"Adzemovic","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2023.114718_bib306","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.4049\/jimmunol.175.6.4119","article-title":"Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice","volume":"175","author":"Spach","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib307","doi-asserted-by":"crossref","first-page":"V2","DOI":"10.1359\/jbmr.07s216","article-title":"Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands","volume":"22","author":"Jurutka","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2023.114718_bib308","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(99)00112-4","article-title":"Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese","volume":"166","author":"Fukazawa","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12031-015-0513-x","article-title":"Vitamin D receptor gene polymorphism and the risk of multiple sclerosis in South Eastern of Iran","volume":"56","author":"Narooie-Nejad","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2023.114718_bib310","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.133.4.1748","article-title":"1, 25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation","volume":"133","author":"Bhalla","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib311","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114718_bib312","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib313","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fphar.2020.00161","article-title":"Calcitriol prevents neuroinflammation and reduces blood-brain barrier disruption and local macrophage\/microglia activation","volume":"11","author":"de Oliveira","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114718_bib314","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0978-3","article-title":"Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties","volume":"14","author":"Prajeeth","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.114718_bib315","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1\u03b1, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib316","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.164.9.4443","article-title":"Carlo, Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"164","author":"Piemonti","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib317","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1\u03b1, 25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib318","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1073\/pnas.78.8.4990","article-title":"Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3","volume":"78","author":"Abe","year":"1981","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114718_bib319","first-page":"5624","article-title":"Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1, 25-dihydroxyvitamin D3 and its fluorinated analogues","volume":"44","author":"Koeffler","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.114718_bib320","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM198904133201506","article-title":"The role of the vitamin D endocrine system in health and disease","volume":"320","author":"Reichel","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.114718_bib321","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jbmr.5650070208","article-title":"1, 25\u2013Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein\u2010specific T cell clone","volume":"7","author":"Lemire","year":"1992","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.biopha.2023.114718_bib322","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.4049\/jimmunol.160.11.5314","article-title":"1, 25-Dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-\u03b21 and IL-4","volume":"160","author":"Cantorna","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114718_bib323","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","article-title":"Cytokine profile in patients with multiple sclerosis following vitamin D supplementation","volume":"134","author":"Mahon","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2023.114718_bib324","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cen3.12398","article-title":"Active form of vitamin D directly protects the blood\u2013brain barrier in multiple sclerosis","volume":"8","author":"Takahashi","year":"2017","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.biopha.2023.114718_bib325","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-5728(99)00247-7","article-title":"1, 25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis","volume":"103","author":"Nashold","year":"2000","journal-title":"J. Neuroimmunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:35:13Z","timestamp":1778247313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223005061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":325,"alternative-id":["S0753332223005061"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114718","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114718"}}